Patients infected with the Omicron variant of COVID-19, who arrived in Russia from South Africa, were earlier vaccinated, their disease is mild, Alexander Gintsburg, director of Russia's Gamaleya National Research Center of Epidemiology and Microbiol ...
Russian developers of the Sputnik V vaccine on Thursday said that their single-dose Sputnik Light vaccine demonstrated 79.4 per cent efficacy against the COVID-19 and it has proven effective against all new strains of coronavirus. ...
The Russian-made Sputnik V coronavirus vaccine has proven equally effective for all age groups, Alexander Gintsburg, the head of the Gamaleya research institute that developed the vaccine, said on Saturday. ...
The Russian-made Sputnik V coronavirus vaccine has proven equally effective for all age groups, Alexander Gintsburg, the head of the Gamaleya research institute that developed the vaccine, said on Saturday. ...
Russia's Gamaleya Institute of Epidemiology and Microbiology has produced a coronavirus vaccine that is patented and more advanced than Western competitors and will be happy to share the technology with foreign colleagues, should they require, the in ...
